(Q39520783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

A Fondell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J Unga

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

E Kullberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J W Park

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

L Gedda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

22 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

Journal of Drug Targeting

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

846-855

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

Clinical trials of targeted alpha therapy for cancer

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Cryo-electron microscopy of vitrified specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Targeting the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Nuclisome: a novel concept for radionuclide therapy using targeting liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

Perspectives on anti-HER monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

The radiobiology of targeted radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.589436

10.3109/1061186X.2011.589436

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692679%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference